Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study

Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study

<p>Abstract</p> <p>Background</p> <p>Simple, non-invasive tests for early detection of degenerative dementia by use of biomarkers are urgently required. However, up to the present, no validated extracerebral diagnostic markers for the early diagnosis of Alzheimer diseas...

Full description

Bibliographic Details
Main Authors:	Antequera Desiree, Bermejo-Pareja Felix, Vargas Teo, Molina Jose A, Carro Eva
Format:	Article
Language:	English
Published:	BMC 2010-11-01
Series:	BMC Neurology
Online Access:	http://www.biomedcentral.com/1471-2377/10/108

Similar Items

Highly specific and ultrasensitive plasma test detects Abeta(1–42) and Abeta(1–40) in Alzheimer’s disease
by: Elisabeth H. Thijssen, et al.
Published: (2021-05-01)

Neuropathology after active Abeta42 immunotherapy: implications for Alzheimer's disease pathogenesis.
by: Boche, Delphine, et al.
Published: (2010)

Cytoplasmic gelsolin increases mitochondrial activity and reduces Aβ burden in a mouse model of Alzheimer's disease
by: Desiree Antequera, et al.
Published: (2009-10-01)

Mitochondrial mislocalization underlies Abeta42-induced neuronal dysfunction in a Drosophila model of Alzheimer's disease.
by: Kanae Iijima-Ando, et al.
Published: (2009-12-01)

The Toll-->NFkappaB signaling pathway mediates the neuropathological effects of the human Alzheimer's Abeta42 polypeptide in Drosophila.
by: Lihua Tan, et al.
Published: (2008-01-01)

Synaptic Alterations in Mouse Models for Alzheimer Disease—A Special Focus on N-Truncated Abeta 4-42
by: Katharina Dietrich, et al.
Published: (2018-03-01)

Bifunctional Modulators of Abeta Aggregation as Potential Agents for Alzheimer's Disease Therapy
by: Li-Hsin Hsu, et al.
Published: (2013)

Is Abeta a sufficient Biomarker for monitoring anti-Abeta clinical studies? A critical review.
by: Jens eMoreth, et al.
Published: (2013-07-01)

Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers II: Sigma-2/PGRMC1 receptors mediate Abeta 42 oligomer binding and synaptotoxicity.
by: Nicholas J Izzo, et al.
Published: (2014-01-01)

Abeta42 mutants with different aggregation profiles induce distinct pathologies in Drosophila.
by: Koichi Iijima, et al.
Published: (2008-01-01)

Abeta42-induced neurodegeneration via an age-dependent autophagic-lysosomal injury in Drosophila.
by: Daijun Ling, et al.
Published: (2009-01-01)

Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits.
by: Nicholas J Izzo, et al.
Published: (2014-01-01)

Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain
by: Boche, D., et al.
Published: (2008)

Effect of active Abeta immunotherapy on neurons in human Alzheimer's disease
by: Paquet, Claire, et al.
Published: (2015)

Abeta42 oligomers trigger synaptic loss through AMPK-dependent activation of mitochondrial fission and mitophagy
by: Lee, Annie
Published: (2018)

A RAT MODEL OF ALZHEIMER´S DISEASE BASED ON ABETA42 AND PRO-OXIDATIVE SUBSTANCES EXHIBITS COGNITIVE DEFICIT AND ALTERATIONS IN GLUTAMATERGIC AND CHOLINERGIC NEUROTRANSMITTER SYSTEMS
by: Tomáš ePetrásek, et al.
Published: (2016-04-01)

Specific Binding of Alzheimer’s Abeta Peptide Fibrils to Single Walled Carbon Nanotubes
by: Steingrimur Stefansson, et al.
Published: (2012-10-01)

Unraveling Alzheimer's disease: insight into the influence of apolipoprotein E isoforms on Abeta aggregation
by: Cerf, Emilie
Published: (2011)

Biomarkers for Alzheimer’s Disease in Saliva: A Systematic Review
by: Helena Sophia Gleerup, et al.
Published: (2019-01-01)

Opposite effects of low and high doses of Abeta42 on electrical network and neuronal excitability in the rat prefrontal cortex.
by: Yun Wang, et al.
Published: (2009-12-01)

Persistent amyloidosis following suppression of Abeta production in a transgenic model of Alzheimer disease.
by: Joanna L Jankowsky, et al.
Published: (2005-12-01)

Persistent amyloidosis following suppression of Abeta production in a transgenic model of Alzheimer disease.
Published: (2005-12-01)

Investigation and treatment of ABeta- and TGF-Beta1- related cerebrovascular dysfunction in Alzheimer's Disease
by: Nicolakakis, Nektaria
Published: (2009)

Spitting image: can saliva biomarkers reflect Alzheimer's disease?
by: Nicholas J. Ashton, et al.
Published: (2021-06-01)

Gelsolin Restores Aβ-Induced Alterations in Choroid Plexus Epithelium
by: Teo Vargas, et al.
Published: (2010-01-01)

Physiological mouse brain Abeta levels are not related to the phosphorylation state of threonine-668 of Alzheimer's APP.
by: Yoshitake Sano, et al.
Published: (2006-12-01)

Inhibition of GSK-3 ameliorates Abeta pathology in an adult-onset Drosophila model of Alzheimer's disease.
by: Oyinkan Sofola, et al.
Published: (2010-09-01)

Soluble megalin is reduced in cerebrospinal fluid samples of Alzheimer´s disease patients
by: Carlos eSpuch, et al.
Published: (2015-04-01)

Optimization of anti-Abeta antibody therapy
by: Karlnoski, Rachel Anne
Published: (2007)

Low-density lipoprotein receptor-related protein 1 (LRP1) mediates neuronal Abeta42 uptake and lysosomal trafficking.
by: Rodrigo A Fuentealba, et al.
Published: (2010-07-01)

Abeta(1-42) Enhances Neuronal Excitability in the CA1 via NR2B Subunit-Containing NMDA Receptors
by: Edina Varga, et al.
Published: (2014-01-01)

Abeta(1-42) induces abnormal alternative splicing of tau exons 2/3 in NGF-induced PC12 cells
by: TERESA LAGUNES, et al.
Published: (2014-12-01)

Towards an early diagnosis of Alzheimer's disease: development of an ATR-FTIR biosensor for the detection of Abeta toxic conformations
by: Kleiren, Emilie
Published: (2013)

Salivary Lactoferrin Expression in a Mouse Model of Alzheimer’s Disease
by: Desiree Antequera, et al.
Published: (2021-09-01)

Mechanism of Early Stage Abeta Amyloid Formation
by: Li, Lei
Published: (2008)

Study of the Pathophysiological Properties of Abeta Aggregates and the Protective Mechanisms of EGb761 against the Cytotoxicity of Abeta Aggregates on PC12 Cells
by: Chang Pei-Teh, et al.
Published: (2002)

Concordant association of insulin degrading enzyme gene (IDE) variants with IDE mRNA, Abeta, and Alzheimer's disease.
by: Minerva M Carrasquillo, et al.
Published: (2010-01-01)

Concordant association of insulin degrading enzyme gene (IDE) variants with IDE mRNA, abeta, and alzheimer's disease.
by: Carrasquillo, Minerva M., et al.
Published: (2010)

How cholesterol constrains glycolipid conformation for optimal recognition of Alzheimer's beta amyloid peptide (Abeta1-40).
by: Nouara Yahi, et al.
Published: (2010-01-01)

Effects of Monoclonal Anti-Abeta Antibodies on the Amyloid Beta Peptide Fibrillogenesis and their Involvement in the Clearance of Alzheimer's Disease Plaques
by: Jimenez, Jeffy Pilar
Published: (2010)

Cannot write session to /tmp/vufind_sessions/sess_v51559f3rclid3pn3arhfnbe65